Brown Shipley & Co’s Bristol-Myers Squibb BMY Stock Holding History

Brown Shipley & Co’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q3	$16.8K	Hold	270	–	–	0.01%	72
2026 Q2	$15.6K	Hold	270	–	–	0.01%	68
2026 Q1	$16.4K	Hold	270	–	–	0.01%	67
2025 Q4	$14.6K	Buy	+270	New	+$13K	0.01%	67
2024 Q4	–	Sell	-235	Closed	-$12.2K	–	66
2024 Q3	$12.2K	Hold	235	–	–	0.01%	65
2024 Q2	$9.8K	Sell	235 -7,341	-97%	-$328K	﹤0.01%	70
2024 Q1	$402K	Sell	7,576 -56	-0.7%	-$2.85K	0.13%	46
2023 Q4	$392K	Sell	7,632 -303	-4%	-$15.9K	0.19%	42
2023 Q3	$461K	Sell	7,935 -1,226	-13%	-$75.1K	0.25%	42
2023 Q2	$586K	Buy	9,161 +164	+2%	+$11K	0.24%	47
2023 Q1	$624K	Buy	+8,997	New	+$635K	0.4%	35

Other funds holding BMY

Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return

Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 26.62% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return

Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $54.1B AUM 39.29% 1-Year Est. Return

Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return

DekaBank Deutsche Girozentrale Frankfurt, Germany $87.8B AUM 20.94% 1-Year Est. Return

Mitsubishi UFJ Asset Management Tokyo, Japan $194B AUM 32.2% 1-Year Est. Return

Brown Shipley & Co's BMY Position: Q3 2026 in Review

Brown Shipley & Co held its Bristol-Myers Squibb (BMY) position steady in Q3 2026 at 270 shares worth $16.8K. The position accounts for 0.01% of the portfolio, ranked #72.

Brown Shipley & Co first reported a position in BMY in Q1 2023 and has held it in 11 quarters since. The position peaked at $624K in Q1 2023. 1,520 funds tracked by Wall St. Rank hold BMY as of Q3 2026.

Brown Shipley & Co held 270 shares of Bristol-Myers Squibb worth $16.8K as of Q3 2026.
Brown Shipley & Co left its Bristol-Myers Squibb share count unchanged in Q3 2026.
Bristol-Myers Squibb made up 0.01% of Brown Shipley & Co's portfolio in Q3 2026, its #72 holding.
Brown Shipley & Co first reported a position in Bristol-Myers Squibb in Q1 2023 and has held it in 11 quarters since.
Brown Shipley & Co's Bristol-Myers Squibb position peaked at $624K in Q1 2023.
1,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q3 2026.

Based on Brown Shipley & Co's 13F filing for Q3 2026, filed 9 Oct 2026.